Skip to main content
. 2022 Apr 20;15:4195–4208. doi: 10.2147/IJGM.S345884

Figure 8.

Figure 8

Molecular docking analysis of ketamine and CHRM1 protein. (A) Crystal structure of the active site-binding ligand KET of CHRM1 (PDB ID: 6WJC). (B) 3D docking and molecular interactions of CHRM1 and KET, the interaction bonds are represented by dashed lines. (C) Pocket view of KET bound to CHRM1. (D) Two-dimensional docking pattern of KET with amino acids TYR,381 TYR,404 TYR,408 ASP105 of CHRM1.